Page 22 - முதலீட்டாளர் உறவுகள் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Prothena Corporation plc: Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, April 07, 2021 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, today announced that in connection with hiring Dr. Hideki Garren as Prothena s Chief Medical Officer, the compensation committee of the Company s board of directors granted Dr. Garren, an option to purchase 250,000 ordinary shares of the Company. Such stock option has an exercise price per share equal to $24.90, which was the closing trading price on April 5, 2021, the date of the grant. In addition, in connection with hiring a new employee, the compensation committee of the Company s board of directors granted the individual an option to purchase 30,000 ordinary shares of the Company. Such stock option has an exercise pr

Ellen roseJennifer zibudaHead of communicationsInvestor relations communicationsProthena corporationCompany on twitter prothenacorpHideki garrenChief medical officerInducement incentive planNasdaq global marketInvestor relationsஎல்லன் உயர்ந்ததுதலை ஆஃப் தகவல்தொடர்புகள்முதலீட்டாளர் உறவுகள் தகவல்தொடர்புகள்ஹைடீகீ கர்ரேன்தலைமை மருத்துவ அதிகாரி